abstract |
The present invention relates to a compound of formula 1 (the contents of each group are described in the specification), stereoisomers thereof, physiologically acceptable salts thereof, and production methods thereof. The compounds of the present invention are suitable for the treatment of metabolic diseases such as type 2 diabetes. [Chemical 1] |